A Novel Albumin Gene Mutation (R222I) in Familial Dysalbuminemic Hyperthyroxinemia

Context: Familial dysalbuminemic hyperthyroxinemia, characterized by abnormal circulating albumin with increased T4 affinity, causes artefactual elevation of free T4 concentrations in euthyroid individuals. Objective: Four unrelated index cases with discordant thyroid function tests in different assay platforms were investigated. Design and Results: Laboratory biochemical assessment, radiolabeled T4 binding studies, and ALB sequencing were undertaken. 125I-T4 binding to both serum and albumin in affected individuals was markedly increased, comparable with known familial dysalbuminemic hyperthyroxinemia cases. Sequencing showed heterozygosity for a novel ALB mutation (arginine to isoleucine at codon 222, R222I) in all four cases and segregation of the genetic defect with abnormal biochemical phenotype in one family. Molecular modeling indicates that arginine 222 is located within a high-affinity T4 binding site in albumin, with substitution by isoleucine, which has a smaller side chain predicted to reduce steric hindrance, thereby facilitating T4 and rT3 binding. When tested in current immunoassays, serum free T4 values from R222I heterozygotes were more measurably abnormal in one-step vs two-step assay architectures. Total rT3 measurements were also abnormally elevated. Conclusions: A novel mutation (R222I) in the ALB gene mediates dominantly inherited dysalbuminemic hyperthyroxinemia. Susceptibility of current free T4 immunoassays to interference by this mutant albumin suggests likely future identification of individuals with this variant binding protein.

[1]  F. Sweep,et al.  Spuriously high free thyroxine values in familial dysalbuminemic hyperthyroxinemia. , 2011, Clinical chemistry.

[2]  A. Pinchera,et al.  Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. , 2009, Clinical chemistry.

[3]  Shek Cc,et al.  A Chinese family with familial dysalbuminaemic hyperthyroxinaemia. , 2003 .

[4]  Chung-Eun Ha,et al.  Structural basis of albumin–thyroxine interactions and familial dysalbuminemic hyperthyroxinemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. L. Choi,et al.  A Chinese family with familial dysalbuminaemic hyperthyroxinaemia. , 2003, Hong Kong medical journal = Xianggang yi xue za zhi.

[6]  R. Weiss,et al.  Familial dysalbuminemic hyperthyroxinemia in a Swiss family caused by a mutant albumin (R218P) shows an apparent discrepancy between serum concentration and affinity for thyroxine. , 2000, The Journal of clinical endocrinology and metabolism.

[7]  J. Feix,et al.  Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype. , 1999, Clinical chemistry.

[8]  S. Refetoff,et al.  Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect. , 1998, The Journal of clinical endocrinology and metabolism.

[9]  T. Koike,et al.  A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. , 1997, The Journal of clinical endocrinology and metabolism.

[10]  D. Jameson,et al.  Mutations in a Specific Human Serum Albumin Thyroxine Binding Site Define the Structural Basis of Familial Dysalbuminemic Hyperthyroxinemia* , 1996, The Journal of Biological Chemistry.

[11]  Y. Hayashi,et al.  An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. , 1994, Biochemical and biophysical research communications.

[12]  M. Mandel,et al.  A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia. , 1994, Journal of medical genetics.

[13]  J. Faber,et al.  Familial Dysalbuminaemic Hyperthyroxinaemia: A Review , 1988, Journal of the Royal Society of Medicine.

[14]  G. Klee,et al.  Thyroid dysfunction. , 1988, Endocrinology and metabolism clinics of North America.

[15]  L. Braverman,et al.  Prevalence of familial dysalbuminemic hyperthyroxinemia in Hispanics. , 1987, Annals of internal medicine.

[16]  M. F. Stewart,et al.  Thyroid Function Tests in Patients with Familial Dysalbuminaemic Hyperthyroxinaemia (FDH) , 1986, Annals of clinical biochemistry.

[17]  K. Chung,et al.  AMIODARONE AND THE THYROID , 1979, The Lancet.